Call Us - We're Easy to Talk To (214) 999-9999

FDA Considers Adding Antidepressant Warning to Tamoxifen Label

Bloomberg News reports, “US regulators may warn patients taking tamoxifen, a breast cancer medicine…not to use certain types of antidepressants because they block the tumor-fighting drug’s effectiveness.” According to Karen Riley, a spokeswoman for the FDA, the agency is considering “‘adding new information to the tamoxifen label’ to advise women taking the cancer drug against using some antidepressants.” The move follows new evidence, presented a study May 30 at the meeting of the American Society of Clinical Oncology, that “tumors were more than twice as likely to return after two years in women taking the antidepressants while on the cancer drug, compared with those taking tamoxifen alone.”

From the American Association for Justice news release.

Bob Kraft

I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law and Social Security Disability.

About This Blog

The title of this blog reflects my attitude toward those government agencies and insurance companies that routinely mistreat injured or disabled people. As a Dallas, Texas lawyer, I've spent more than 45 years trying to help those poor folk, and I have been frustrated daily by the actions of the people on the other side of their claims. (Sorry if I offended you...)

If you find this type of information interesting or helpful, please visit my law firm's main website at KraftLaw.com. You will find many more articles and links. Thank you for your time.

Find us on your preferred network